Hengrui Pharmaceutical: Completed buyback plan with a total expenditure of approximately 600 million yuan.

Hengrui Medicine Announcement, on May 14, 2025, the deadline for the company's share repurchase has expired, and the share repurchase has been completed. The actual repurchased shares of the company are 12,905,144 shares, accounting for 0.20% of the total share capital of the company. The highest transaction price is 57.01 yuan/share, the lowest transaction price is 39.00 yuan/share, and the average repurchase price is about 46.59 yuan/share. The total transaction amount is 601,267,615.04 yuan.